NYSE:ZBH - Zimmer Biomet Stock Price, Price Target & More

$115.10 +4.51 (+4.08 %)
(As of 04/26/2018 04:00 PM ET)
Previous Close$110.59
Today's Range$107.69 - $115.23
52-Week Range$104.28 - $133.49
Volume3.07 million shs
Average Volume1.31 million shs
Market Capitalization$22.23 billion
P/E Ratio14.33
Dividend Yield0.88%
Beta1.17

About Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet logoZimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products; and bone cement and spinal fusion stimulators. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Receive ZBH News and Ratings via Email

Sign-up to receive the latest news and ratings for ZBH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
SymbolNYSE:ZBH
CUSIPN/A
Phone574-267-6131

Debt

Debt-to-Equity Ratio0.76%
Current Ratio1.50%
Quick Ratio0.81%

Price-To-Earnings

Trailing P/E Ratio14.33
Forward P/E Ratio14.76
P/E Growth1.91

Sales & Book Value

Annual Sales$7.82 billion
Price / Sales2.99
Cash Flow$15.7456 per share
Price / Cash7.31
Book Value$57.96 per share
Price / Book1.99

Profitability

EPS (Most Recent Fiscal Year)$8.03
Net Income$1.81 billion
Net Margins23.51%
Return on Equity15.45%
Return on Assets6.19%

Miscellaneous

Employees18,200
Outstanding Shares203,150,000

How to Become a New Pot Stock Millionaire

Zimmer Biomet (NYSE:ZBH) Frequently Asked Questions

What is Zimmer Biomet's stock symbol?

Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

How often does Zimmer Biomet pay dividends? What is the dividend yield for Zimmer Biomet?

Zimmer Biomet announced a quarterly dividend on Monday, March 12th. Stockholders of record on Thursday, March 29th will be given a dividend of $0.24 per share on Monday, April 30th. This represents a $0.96 annualized dividend and a dividend yield of 0.83%. The ex-dividend date is Wednesday, March 28th. View Zimmer Biomet's Dividend History.

How were Zimmer Biomet's earnings last quarter?

Zimmer Biomet (NYSE:ZBH) posted its earnings results on Wednesday, April, 25th. The medical equipment provider reported $1.91 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.89 by $0.02. The medical equipment provider earned $2.02 billion during the quarter, compared to analysts' expectations of $1.98 billion. Zimmer Biomet had a return on equity of 15.45% and a net margin of 23.51%. The company's revenue for the quarter was up 2.1% on a year-over-year basis. During the same quarter last year, the company posted $2.13 EPS. View Zimmer Biomet's Earnings History.

When is Zimmer Biomet's next earnings date?

Zimmer Biomet is scheduled to release their next quarterly earnings announcement on Thursday, April, 26th 2018. View Earnings Estimates for Zimmer Biomet.

What guidance has Zimmer Biomet issued on next quarter's earnings?

Zimmer Biomet issued an update on its FY18 earnings guidance on Thursday, April, 26th. The company provided earnings per share (EPS) guidance of $7.60-$7.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.80. The company issued revenue guidance of $7.94-$8.09 billion, compared to the consensus revenue estimate of $7.96 billion.

What price target have analysts set for ZBH?

23 analysts have issued 1-year target prices for Zimmer Biomet's shares. Their forecasts range from $115.00 to $168.00. On average, they anticipate Zimmer Biomet's stock price to reach $138.80 in the next twelve months. View Analyst Ratings for Zimmer Biomet.

What are Wall Street analysts saying about Zimmer Biomet stock?

Here are some recent quotes from research analysts about Zimmer Biomet stock:
  • 1. Canaccord Genuity analysts commented, "We are updating our model to reflect Zimmer’s adoption of several previously disclosed new accounting standards (revenue recognition for customer contracts, reporting of pension costs, and hedging activities). The company adopted the changes effective January 1, 2018, and recently provided updated historical financials (for 2016 and 2017) to reflect a retrospective adoption of the new standards. While the new accounting policies have not resulted in any material changes to 2016 and 2017 historical results, we have nonetheless updated our model to reflect how the company will report moving forward. Additionally, we have also tweaked our forward estimates to incorporate a slightly more conservative revenue ramp in 2018/2019 and higher COGS and operating spend related to the quality/manufacturing remediation and sales channel incentives/ investments. Thus we maintain our HOLD rating and lower our price target to $121." (4/12/2018)
  • 2. Cantor Fitzgerald analysts commented, "ZBH received FDA clearance for its Persona cementless knee, earlier than we expected." (2/5/2018)
  • 3. According to Zacks Investment Research, "Zimmer Biomet ended the third quarter 2017 on a dismal note with earnings below the Zacks Consensus Estimate and revenues in line with the same. Sales were declining within most of the core segments primarily due to the slower pace of supply recovery and sales recapture of certain key brands particularly in the United States and softened domestic market conditions. The lowered 2017 guidance also added to our concerns indicating little chances of recovery ahead. Over, the last three months, the company has been observed to trade below the broader industry. Nevertheless, we look forward to the expected synergy from the LDR Holding acquisition, which should broaden and complement the company's musculoskeletal offering. We are also impressed by the strong strategic and financial goals which the combined entity expects to reach, now that the deal has been closed." (11/20/2017)

Who are some of Zimmer Biomet's key competitors?

Who are Zimmer Biomet's key executives?

Zimmer Biomet's management team includes the folowing people:
  • Mr. Daniel P. Florin Sr., Exec. VP & CFO (Age 54)
  • Mr. Chad F. Phipps, Sr. VP, Gen. Counsel & Sec. (Age 46)
  • Dr. Katarzyna Mazur-Hofsaess, Pres of Europe, Middle East & Africa (Age 54)
  • Mr. Sang Yi, Pres of Asia Pacific (Age 56)
  • Mr. Bryan C. Hanson, Pres, CEO & Director (Age 51)

Has Zimmer Biomet been receiving favorable news coverage?

News stories about ZBH stock have trended somewhat positive on Thursday, according to Accern Sentiment. The research firm identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Zimmer Biomet earned a media sentiment score of 0.10 on Accern's scale. They also assigned media stories about the medical equipment provider an impact score of 46.64 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

How do I buy shares of Zimmer Biomet?

Shares of ZBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Zimmer Biomet's stock price today?

One share of ZBH stock can currently be purchased for approximately $115.10.

How big of a company is Zimmer Biomet?

Zimmer Biomet has a market capitalization of $22.23 billion and generates $7.82 billion in revenue each year. The medical equipment provider earns $1.81 billion in net income (profit) each year or $8.03 on an earnings per share basis. Zimmer Biomet employs 18,200 workers across the globe.

How can I contact Zimmer Biomet?

Zimmer Biomet's mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The medical equipment provider can be reached via phone at 574-267-6131 or via email at [email protected]


MarketBeat Community Rating for Zimmer Biomet (ZBH)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  594 (Vote Outperform)
Underperform Votes:  466 (Vote Underperform)
Total Votes:  1,060
MarketBeat's community ratings are surveys of what our community members think about Zimmer Biomet and other stocks. Vote "Outperform" if you believe ZBH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ZBH will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Zimmer Biomet (NYSE:ZBH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
23 Wall Street analysts have issued ratings and price targets for Zimmer Biomet in the last 12 months. Their average twelve-month price target is $138.80, suggesting that the stock has a possible upside of 20.59%. The high price target for ZBH is $168.00 and the low price target for ZBH is $115.00. There are currently 6 hold ratings, 16 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.782.822.812.59
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
16 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
16 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
15 Buy Rating(s)
1 Strong Buy Rating(s)
2 Sell Rating(s)
6 Hold Rating(s)
13 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $138.80$140.6316$137.4211$136.55
Price Target Upside: 20.59% upside26.26% upside10.17% upside16.62% upside

Zimmer Biomet (NYSE:ZBH) Consensus Price Target History

Price Target History for Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet (NYSE:ZBH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/12/2018Canaccord GenuityReiterated RatingHold$121.00LowView Rating Details
4/2/2018Evercore ISIInitiated CoverageIn-Line$115.00LowView Rating Details
3/23/2018Robert W. BairdDowngradeOutperform -> NeutralHighView Rating Details
3/15/2018OppenheimerInitiated CoverageOutperform$135.00LowView Rating Details
3/15/2018Raymond JamesInitiated CoverageOutperform$135.00LowView Rating Details
2/27/2018CitigroupLower Price TargetNeutral -> Neutral$132.00 -> $121.00LowView Rating Details
2/26/2018Morgan StanleyLower Price TargetOverweight -> Overweight$150.00 -> $148.00LowView Rating Details
2/5/2018Cantor FitzgeraldReiterated RatingBuy$140.00HighView Rating Details
1/31/2018Leerink SwannBoost Price TargetOutperform -> Outperform$142.00 -> $146.00LowView Rating Details
1/31/2018Stifel NicolausUpgradeHold -> Buy$120.00 -> $168.00LowView Rating Details
1/30/2018BMO Capital MarketsReiterated RatingBuy$144.00LowView Rating Details
1/30/2018Needham & Company LLCBoost Price TargetStrong-Buy -> Strong-Buy$144.00 -> $155.00MediumView Rating Details
1/29/2018SunTrust BanksBoost Price TargetBuy$142.00MediumView Rating Details
12/19/2017Goldman SachsUpgradeSell -> Neutral$125.00LowView Rating Details
12/19/2017Wells FargoUpgradeMarket Perform -> OutperformLowView Rating Details
11/14/2017Deutsche BankUpgradeHold -> Buy$128.00N/AView Rating Details
11/9/2017Edward JonesUpgradeHold -> BuyN/AView Rating Details
11/7/2017Royal Bank of CanadaLower Price TargetOutperform$125.00N/AView Rating Details
11/3/2017Jefferies GroupReiterated RatingBuy$136.00N/AView Rating Details
11/2/2017Piper JaffrayDowngradeOverweight -> NeutralN/AView Rating Details
8/24/2017GabelliInitiated CoverageBuy$142.00LowView Rating Details
7/14/2017Bank of AmericaReiterated RatingBuy -> Buy$158.00MediumView Rating Details
7/12/2017GuggenheimUpgradeNeutral -> Buy$157.00MediumView Rating Details
1/5/2017JPMorgan ChaseSet Price TargetBuy$134.00N/AView Rating Details
12/21/2016UBSDowngradeNeutral -> Sell$113.00 -> $100.00N/AView Rating Details
11/8/2016Northcoast ResearchDowngradeBuy -> NeutralN/AView Rating Details
9/22/2016ArgusReiterated RatingBuy$140.00N/AView Rating Details
8/23/2016BarclaysBoost Price TargetOverweight$140.00 -> $145.00N/AView Rating Details
7/29/2016JMP SecuritiesBoost Price TargetMarket Outperform$131.00 -> $145.00N/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
(Data available from 4/26/2016 forward)

Earnings

Zimmer Biomet (NYSE:ZBH) Earnings History and Estimates Chart

Earnings by Quarter for Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet (NYSE:ZBH) Earnings Estimates

2018 EPS Consensus Estimate: $7.78
2019 EPS Consensus Estimate: $8.21
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20186$1.85$1.98$1.89
Q2 20186$1.85$1.97$1.91
Q3 20186$1.73$1.84$1.79
Q4 20186$2.13$2.28$2.19
Q1 20192$1.98$2.04$2.01
Q2 20192$2.00$2.07$2.04
Q3 20192$1.87$1.91$1.89
Q4 20192$2.26$2.28$2.27

Zimmer Biomet (NYSE ZBH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/2018        
4/25/2018Q1 2018$1.89$1.91$1.9805 billion$2.0180 billionViewN/AView Earnings Details
1/30/2018Q4 2017$2.0980$2.10$2.0286 billion$2.0743 billionViewListenView Earnings Details
11/1/2017Q3 2017$1.74$1.72$1.8291 billion$1.8180 billionViewN/AView Earnings Details
7/27/2017Q2 2017$2.10$2.08$1.9541 billion$1.9544 billionViewN/AView Earnings Details
4/27/2017Q1 2017$2.1110$2.13$1.9607 billion$1.9773 billionViewN/AView Earnings Details
1/31/2017Q416$2.11$2.14$1.98 billion$2.01 billionViewListenView Earnings Details
10/31/2016Q316$1.79$1.79$950.20 million$1.83 billionViewListenView Earnings Details
7/28/2016Q216$1.97$2.02$1.90 billion$1.93 billionViewListenView Earnings Details
4/28/2016Q116$1.93$2.00$1.88 billion$1.90 billionViewListenView Earnings Details
1/28/2016Q415$2.04$2.09$1.96 billion$1.98 billionViewListenView Earnings Details
10/29/2015Q315$1.56$1.64$1.76 billion$1.76 billionViewListenView Earnings Details
7/30/2015Q2 2015$1.56$1.59$1.1429 billion$1.1676 billionViewN/AView Earnings Details
4/30/2015Q115$1.54$1.58$1.15 billion$1.13 billionViewN/AView Earnings Details
1/29/2015Q414$1.71$0.91$1.25 billion$1.22 billionViewN/AView Earnings Details
10/23/2014Q314$1.00$0.96$1.10 billion$1.11 billionViewListenView Earnings Details
7/24/2014Q214$1.49$1.49$1.21 billion$1.18 billionViewN/AView Earnings Details
4/24/2014Q114$1.47$1.50$1.18 billion$1.16 billionViewListenView Earnings Details
1/31/2014Q114$1.62$1.36$1.22 billion$1.24 billionViewN/AView Earnings Details
10/24/2013Q313$1.24$1.25$1.06 billion$1.07 billionViewN/AView Earnings Details
7/25/2013Q2 2013$1.44$1.43$1.15 billion$1.17 billionViewN/AView Earnings Details
4/25/2013Q1 2013$1.40$1.41$1.14 billion$1.14 billionViewN/AView Earnings Details
1/31/2013Q4 2012$1.49$1.51$1.17 billion$1.18 billionViewN/AView Earnings Details
10/25/2012$1.13$1.15ViewN/AView Earnings Details
7/26/2012$1.32$1.34ViewN/AView Earnings Details
4/26/2012$1.30$1.30ViewN/AView Earnings Details
1/26/2012$1.34$1.36ViewN/AView Earnings Details
10/27/2011$1.03$1.04ViewN/AView Earnings Details
7/27/2011$1.19$1.21ViewN/AView Earnings Details
4/28/2011$1.12$1.19ViewN/AView Earnings Details
1/27/2011$1.19$1.21ViewN/AView Earnings Details
10/28/2010Q3 2010$0.95$0.96ViewN/AView Earnings Details
7/22/2010Q2 2010$1.05$1.09ViewN/AView Earnings Details
4/22/2010Q1 2010$1.01$1.02ViewN/AView Earnings Details
1/28/2010Q4 2009$1.08$1.12ViewN/AView Earnings Details
10/22/2009Q3 2009$0.85$0.88ViewN/AView Earnings Details
7/23/2009Q2 2009$0.96$1.01ViewN/AView Earnings Details
4/23/2009Q1 2009$0.94$0.95ViewN/AView Earnings Details
1/29/2009Q4 2008$1.00$1.00ViewN/AView Earnings Details
10/23/2008Q3 2008$0.89$0.97ViewN/AView Earnings Details
7/22/2008Q2 2008$1.03$1.03ViewN/AView Earnings Details
4/24/2008Q1 2008$1.04$1.04ViewN/AView Earnings Details
1/29/2008Q4 2007$1.04$1.18ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Zimmer Biomet (NYSE:ZBH) Dividend Information

Zimmer Biomet pays an annual dividend of $0.96 per share, with a dividend yield of 0.83%. ZBH's next quarterly dividend payment will be made on Monday, April 30. Zimmer Biomet pays out 11.96% of its earnings out as a dividend.
Next Dividend:4/30/2018
Annual Dividend:$0.96
Dividend Yield:0.83%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:11.96% (Trailing 12 Months of Earnings)
12.31% (Based on This Year's Estimates)
11.52% (Based on Next Year's Estimates)
Track Record:2 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet (NYSE:ZBH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/12/2018quarterly$0.240.88%3/28/20183/29/20184/30/2018
12/18/2017quarterly$0.240.79%12/28/201712/29/20171/29/2018
8/7/2017quarterly$0.240.83%9/21/20179/22/201710/27/2017
5/30/2017quarterly$0.240.81%6/21/20176/23/20177/28/2017
3/1/2017quarterly$0.240.81%3/29/20173/31/20174/28/2017
12/19/2016quarterly$0.240.94%12/28/201612/30/20161/27/2017
8/23/2016quarterly$0.240.74%9/21/20169/23/201610/28/2016
5/23/2016quarterly$0.246/22/20166/24/20167/29/2016
2/24/2016quarterly$0.240.99%3/29/20163/31/20164/29/2016
12/14/2015quarterly$0.220.87%12/29/201512/31/20151/29/2016
8/24/2015quarterly$0.220.9%9/28/20159/30/201510/30/2015
5/5/2015quarterly$0.220.8%5/13/20155/15/20157/14/2015
2/24/2015quarterly$0.220.73%3/4/20153/6/20154/24/2015
12/15/2014quarterly$0.220.81%12/24/201412/29/20141/30/2015
8/26/2014quarterly$0.220.87%9/24/20149/26/201410/31/2014
5/23/2014quarterly$0.220.86%6/25/20146/27/20147/25/2014
3/5/2014quarterly$0.220.9%3/26/20143/28/20144/25/2014
12/16/2013quarterly$0.200.88%12/24/201312/27/20131/31/2014
9/9/2013quarterly$0.200.99%9/25/20139/27/201310/25/2013
6/14/2013quarterly$0.201.03%6/26/20136/28/20137/26/2013
3/8/2013quarterly$0.201.06%3/26/20133/29/20134/26/2013
12/14/2012quarterly$0.181.06%12/24/201212/27/20121/25/2013
(Data available from 1/1/2013 forward)

Insider Trades

Zimmer Biomet (NYSE ZBH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.71%
Institutional Ownership Percentage: 86.28%
Insider Trading History for Zimmer Biomet (NYSE:ZBH)
Institutional Ownership by Quarter for Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet (NYSE ZBH) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/20/2018Bryan C HansonInsiderBuy25,077$119.68$3,001,215.36View SEC Filing  
2/12/2018Chad F. PhippsVPSell20,826$115.95$2,414,774.70View SEC Filing  
7/31/2017Tony W. CollinsVPSell16,986$121.74$2,067,875.64View SEC Filing  
6/12/2017Sang YiInsiderSell17,731$124.56$2,208,573.36View SEC Filing  
5/5/2017Chad F. PhippsVPSell6,200$116.76$723,912.00View SEC Filing  
4/27/2017David C DvorakInsiderSell87,331$116.47$10,171,441.57381,886View SEC Filing  
3/20/2017David C DvorakInsiderSell1,040$121.63$126,495.20294,077View SEC Filing  
12/2/2016David A. Jr. NolanInsiderSell5,050$101.11$510,605.50View SEC Filing  
9/8/2016Daniel E WilliamsonInsiderSell2,716$129.96$352,971.362,000View SEC Filing  
8/23/2016Stuart G KleopferInsiderSell3,397$129.71$440,624.873,000View SEC Filing  
8/12/2016Tony W. CollinsVPSell1,287$129.16$166,228.92View SEC Filing  
8/9/2016Stuart G KleopferInsiderSell533$132.71$70,734.436,397View SEC Filing  
8/1/2016David A. Jr. NolanInsiderSell25,255$130.77$3,302,596.35View SEC Filing  
7/11/2016Daniel P FlorinCFOSell15,000$124.98$1,874,700.0016,983View SEC Filing  
6/14/2016Tony W CollinsCAOSell3,611$116.43$420,428.733,245View SEC Filing  
6/9/2016Stuart G KleopferInsiderSell11,000$119.45$1,313,950.007,609View SEC Filing  
4/14/2016Daniel P FlorinCFOSell10,000$114.98$1,149,800.0028,415View SEC Filing  
4/12/2016Daniel P FlorinCFOSell12,000$110.00$1,320,000.0038,415View SEC Filing  
3/21/2016David C DvorakCEOSell1,540$104.16$160,406.40277,416View SEC Filing  
2/10/2016Blackstone Capital Partners VMajor ShareholderSell7,351,708$95.91$705,102,314.28View SEC Filing  
1/8/2016David C. DvorakCEOSell44,661$102.46$4,575,966.06244,502View SEC Filing  
12/2/2015David A. Jr. NolaninsiderSell3,435$102.62$352,499.7012,139View SEC Filing  
6/30/2015Adam Rudolph JohnsonInsiderSell30,600$110.34$3,376,404.00View SEC Filing  
6/29/2015Daniel E WilliamsonInsiderSell16,000$110.98$1,775,680.00View SEC Filing  
6/29/2015Daniel P FlorinCFOSell5,000$107.00$535,000.00View SEC Filing  
3/17/2015David C DvorakCEOSell1,300$115.55$150,215.00View SEC Filing  
12/5/2014David C DvorakCEOSell48,703$115.00$5,600,845.00View SEC Filing  
11/28/2014Chad F PhippsVPSell5,000$112.00$560,000.00View SEC Filing  
11/3/2014Katarzyna Mazur-HofsaessInsiderSell28,253$110.01$3,108,112.53View SEC Filing  
9/9/2014Stephen Hong Liang OoiInsiderSell40,768$102.78$4,190,135.04View SEC Filing  
8/26/2014James T CrinesCFOSell40,768$101.00$4,117,568.00View SEC Filing  
1/8/2014Jeffery MccaulleyInsiderSell21,286$96.00$2,043,456.005,211View SEC Filing  
1/7/2014Chad PhippsVPSell7,000$95.00$665,000.0017,240View SEC Filing  
12/20/2013Jeffery MccaulleyInsiderSell21,286$93.00$1,979,598.005,211View SEC Filing  
12/3/2013Jeffery MccaulleyInsiderSell2,713$90.12$244,495.565,211View SEC Filing  
11/15/2013Derek DavisCAOSell3,500$90.20$315,700.002,791View SEC Filing  
11/14/2013Chad PhippsVPSell7,800$90.00$702,000.0017,240View SEC Filing  
11/14/2013David DvorakCEOSell64,763$90.00$5,828,670.00172,746View SEC Filing  
11/14/2013Jeffery MccaulleyInsiderSell21,285$90.00$1,915,650.007,924View SEC Filing  
9/13/2013Katarzyna Mazur-HofsaessInsiderSell4,890$81.38$397,948.201,643View SEC Filing  
8/1/2013James T CrinesCFOSell46,200$84.56$3,906,672.00View SEC Filing  
8/1/2013Stephen Hong Liang OoiInsiderSell38,500$84.27$3,244,395.00View SEC Filing  
7/29/2013Derek M DavisCAOSell3,725$83.78$312,080.50View SEC Filing  
7/29/2013Jeffery A MccaulleyInsiderSell112,255$83.40$9,362,067.00View SEC Filing  
7/19/2013Chad F PhippsVPSell6,000$83.00$498,000.00View SEC Filing  
5/8/2013Chad F PhippsVPSell5,000$77.26$386,300.00View SEC Filing  
4/30/2013James T CrinesCFOSell25,000$76.08$1,902,000.00View SEC Filing  
4/30/2013Jeffery A MccaulleyInsiderSell10,000$76.08$760,800.00View SEC Filing  
2/4/2013Derek M DavisCAOSell21,864$72.53$1,585,795.92View SEC Filing  
2/4/2013Jeffery A MccaulleyInsiderSell12,000$73.60$883,200.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Zimmer Biomet (NYSE ZBH) News Headlines

Source:
DateHeadline
Zimmer Biomet (ZBH) Expected to Post Earnings of $1.87 Per ShareZimmer Biomet (ZBH) Expected to Post Earnings of $1.87 Per Share
www.americanbankingnews.com - April 26 at 7:18 PM
Zimmer Biomet Q1 revenues up 2%; updates guidanceZimmer Biomet Q1 revenues up 2%; updates guidance
seekingalpha.com - April 26 at 5:01 PM
Zimmer Biomets (ZBH) CEO Bryan Hanson on Q1 2018 Results - Earnings Call TranscriptZimmer Biomet's (ZBH) CEO Bryan Hanson on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - April 26 at 5:01 PM
Zimmer Biomet (ZBH) Q1 Earnings Top Estimates, Margins DropZimmer Biomet (ZBH) Q1 Earnings Top Estimates, Margins Drop
finance.yahoo.com - April 26 at 5:01 PM
Zimmer Biomet (ZBH) Announces Quarterly  Earnings ResultsZimmer Biomet (ZBH) Announces Quarterly Earnings Results
www.americanbankingnews.com - April 26 at 4:36 PM
Zimmer Biomet (ZBH) Issues FY18 Earnings GuidanceZimmer Biomet (ZBH) Issues FY18 Earnings Guidance
www.americanbankingnews.com - April 26 at 11:19 AM
Zimmer Biomet beats by $0.02, beats on revenueZimmer Biomet beats by $0.02, beats on revenue
seekingalpha.com - April 26 at 8:36 AM
Zimmer Biomet profit slides 42%Zimmer Biomet profit slides 42%
www.marketwatch.com - April 26 at 8:36 AM
Zimmer Biomet (ZBH) Beats on Q1 Earnings & Revenue EstimatesZimmer Biomet (ZBH) Beats on Q1 Earnings & Revenue Estimates
finance.yahoo.com - April 26 at 8:36 AM
Interesting ZBH Put And Call Options For December 21stInteresting ZBH Put And Call Options For December 21st
www.nasdaq.com - April 25 at 5:12 PM
Royal Bank of Canada Increases Zimmer Biomet (ZBH) Price Target to $140.00Royal Bank of Canada Increases Zimmer Biomet (ZBH) Price Target to $140.00
www.americanbankingnews.com - April 20 at 6:24 PM
Zimmer Biomet (ZBH) Earns Buy Rating from BMO Capital MarketsZimmer Biomet (ZBH) Earns Buy Rating from BMO Capital Markets
www.americanbankingnews.com - April 19 at 5:50 PM
Zimmer Biomet (ZBH) Upgraded to "Buy" by GuggenheimZimmer Biomet (ZBH) Upgraded to "Buy" by Guggenheim
www.americanbankingnews.com - April 18 at 9:10 PM
Oregon Surgical Institute to Implement Zimmer Biomet Signature Solutions Outpatient ProgramOregon Surgical Institute to Implement Zimmer Biomet Signature Solutions Outpatient Program
finance.yahoo.com - April 18 at 5:24 PM
Consort Medical (CSRMY) vs. Zimmer Biomet (ZBH) Head-To-Head ComparisonConsort Medical (CSRMY) vs. Zimmer Biomet (ZBH) Head-To-Head Comparison
www.americanbankingnews.com - April 18 at 11:30 AM
Zimmer Biomet (ZBH) Set to Announce Quarterly Earnings on WednesdayZimmer Biomet (ZBH) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 18 at 2:28 AM
VisionGate, Inc. Appoints Randal Buness as Chief Financial OfficerVisionGate, Inc. Appoints Randal Buness as Chief Financial Officer
feeds.benzinga.com - April 17 at 8:13 PM
FY2019 EPS Estimates for Zimmer Biomet (ZBH) Decreased by Leerink SwannFY2019 EPS Estimates for Zimmer Biomet (ZBH) Decreased by Leerink Swann
www.americanbankingnews.com - April 17 at 6:51 AM
Can S.E.T. Aid Zimmer (ZBH) Q1 Earnings Despite Supply Woes?Can S.E.T. Aid Zimmer (ZBH) Q1 Earnings Despite Supply Woes?
finance.yahoo.com - April 16 at 5:02 PM
Zimmer Biomet Announces FDA Clearance and First Surgical Case of the Persona® Trabecular Metal™ TibiaZimmer Biomet Announces FDA Clearance and First Surgical Case of the Persona® Trabecular Metal™ Tibia
finance.yahoo.com - April 16 at 5:02 PM
Zimmer Biomet (ZBH) Receives Average Recommendation of "Buy" from AnalystsZimmer Biomet (ZBH) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - April 15 at 6:59 AM
Zimmer Biomet (ZBH) Stock Rating Reaffirmed by Canaccord GenuityZimmer Biomet (ZBH) Stock Rating Reaffirmed by Canaccord Genuity
www.americanbankingnews.com - April 12 at 9:35 PM
 Analysts Expect Zimmer Biomet Holdings Inc (ZBH) Will Announce Quarterly Sales of $1.98 Billion Analysts Expect Zimmer Biomet Holdings Inc (ZBH) Will Announce Quarterly Sales of $1.98 Billion
www.americanbankingnews.com - April 11 at 2:04 AM
Zimmer Biomet (ZBH) Given a $137.00 Price Target by Oppenheimer AnalystsZimmer Biomet (ZBH) Given a $137.00 Price Target by Oppenheimer Analysts
www.americanbankingnews.com - April 10 at 5:37 PM
Zimmer Biomet Holdings Inc (ZBH) Expected to Post Earnings of $1.87 Per ShareZimmer Biomet Holdings Inc (ZBH) Expected to Post Earnings of $1.87 Per Share
www.americanbankingnews.com - April 9 at 9:20 PM
Supply Delay Hits Zimmer Biomet, Operational Plan Buoys HopeSupply Delay Hits Zimmer Biomet, Operational Plan Buoys Hope
finance.yahoo.com - April 9 at 5:02 PM
Zimmer Biomet (ZBH) Earns "Buy" Rating from SunTrust BanksZimmer Biomet (ZBH) Earns "Buy" Rating from SunTrust Banks
www.americanbankingnews.com - April 8 at 4:51 PM
Why Trumps Tariffs Could Raise the Cost of a Hip ReplacementWhy Trump's Tariffs Could Raise the Cost of a Hip Replacement
www.nytimes.com - April 7 at 9:01 AM
MSA Safety (MSA) and Zimmer Biomet (ZBH) Critical ContrastMSA Safety (MSA) and Zimmer Biomet (ZBH) Critical Contrast
www.americanbankingnews.com - April 5 at 1:20 AM
Zimmer Biomet Holdings (ZBH) Reports FDA Clearance of Comprehensive Augmented Baseplate for Shoulder ReconstructionZimmer Biomet Holdings (ZBH) Reports FDA Clearance of Comprehensive Augmented Baseplate for Shoulder Reconstruction
www.streetinsider.com - April 3 at 8:51 AM
Zimmer Biomet (ZBH) Research Coverage Started at Evercore ISIZimmer Biomet (ZBH) Research Coverage Started at Evercore ISI
www.americanbankingnews.com - April 2 at 5:18 PM
Zimmer Biomet Announces FDA Clearance of the Comprehensive® Augmented Baseplate for Shoulder ReconstructionZimmer Biomet Announces FDA Clearance of the Comprehensive® Augmented Baseplate for Shoulder Reconstruction
finance.yahoo.com - April 2 at 5:07 PM
Zimmer Biomet (ZBH) Cut to Neutral at Piper JaffrayZimmer Biomet (ZBH) Cut to Neutral at Piper Jaffray
www.americanbankingnews.com - April 2 at 8:18 AM
Zimmer Biomet (ZBH) Price Target Lowered to $125.00 at Royal Bank of CanadaZimmer Biomet (ZBH) Price Target Lowered to $125.00 at Royal Bank of Canada
www.americanbankingnews.com - April 1 at 3:42 PM
Zimmer Biomet (ZBH) Raised to "Buy" at Edward JonesZimmer Biomet (ZBH) Raised to "Buy" at Edward Jones
www.americanbankingnews.com - March 31 at 6:34 PM
Zimmer Biomets Mobi-C Cervical Disc shows maintains benefit in long-term studyZimmer Biomet's Mobi-C Cervical Disc shows maintains benefit in long-term study
seekingalpha.com - March 29 at 5:09 PM
Zimmer Biomet Spine Announces Mobi-C® Cervical Disc Seven-Year Follow-Up Data Published in International Journal of Spine SurgeryZimmer Biomet Spine Announces Mobi-C® Cervical Disc Seven-Year Follow-Up Data Published in International Journal of Spine Surgery
finance.yahoo.com - March 29 at 8:54 AM
Zimmer Biomet (ZBH) Upgraded to "Buy" at ValuEngineZimmer Biomet (ZBH) Upgraded to "Buy" at ValuEngine
www.americanbankingnews.com - March 28 at 7:05 PM
Zimmer Biomet Joins U.S. Department of Energys Better Buildings, Better Plants ProgramZimmer Biomet Joins U.S. Department of Energy's Better Buildings, Better Plants Program
finance.yahoo.com - March 27 at 8:58 AM
Robert W. Baird Reaffirms "Buy" Rating for Zimmer Biomet (ZBH)Robert W. Baird Reaffirms "Buy" Rating for Zimmer Biomet (ZBH)
www.americanbankingnews.com - March 26 at 12:14 PM
Stifel Nicolaus Upgrades Zimmer Biomet (ZBH) to "Buy"Stifel Nicolaus Upgrades Zimmer Biomet (ZBH) to "Buy"
www.americanbankingnews.com - March 26 at 11:35 AM
$1.98 Billion in Sales Expected for Zimmer Biomet Holdings Inc (ZBH) This Quarter$1.98 Billion in Sales Expected for Zimmer Biomet Holdings Inc (ZBH) This Quarter
www.americanbankingnews.com - March 25 at 2:18 AM
Zimmer Biomet (ZBH) Lowered to Hold at ValuEngineZimmer Biomet (ZBH) Lowered to Hold at ValuEngine
www.americanbankingnews.com - March 23 at 10:14 PM
Zimmer Biomet Holdings Inc (ZBH) Expected to Announce Earnings of $1.88 Per ShareZimmer Biomet Holdings Inc (ZBH) Expected to Announce Earnings of $1.88 Per Share
www.americanbankingnews.com - March 23 at 7:24 PM
Robert W. Baird Lowers Zimmer Biomet (ZBH) to NeutralRobert W. Baird Lowers Zimmer Biomet (ZBH) to Neutral
www.americanbankingnews.com - March 23 at 6:49 PM
Zimmer Biomet Holdings Announces Audio Webcast and Conference Call of First Quarter 2018 ResultsZimmer Biomet Holdings Announces Audio Webcast and Conference Call of First Quarter 2018 Results
finance.yahoo.com - March 22 at 5:15 PM
Zimmer Biomet Holdings Inc (ZBH) Given Average Recommendation of "Buy" by BrokeragesZimmer Biomet Holdings Inc (ZBH) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - March 21 at 5:34 AM
Zimmer Biomet Appoints Coleman N. Lannum as Senior Vice President of Investor RelationsZimmer Biomet Appoints Coleman N. Lannum as Senior Vice President of Investor Relations
finance.yahoo.com - March 19 at 4:56 PM
German defence ministry seeks continuity with new procurement chiefGerman defence ministry seeks continuity with new procurement chief
finance.yahoo.com - March 16 at 6:06 PM
Zimmer Biomet (ZBH) Coverage Initiated at OppenheimerZimmer Biomet (ZBH) Coverage Initiated at Oppenheimer
www.americanbankingnews.com - March 15 at 7:06 PM

SEC Filings

Zimmer Biomet (NYSE:ZBH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Zimmer Biomet (NYSE:ZBH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Zimmer Biomet (NYSE ZBH) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.